Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Squamous Cell Carcinoma of the Oropharynx”

287 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 287 results

Testing effectiveness (Phase 2)Ended earlyNCT01313390
What this trial is testing

Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University College, London 4
Not applicableUnknownNCT00983697
What this trial is testing

FDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N Cancer

Who this might be right for
Head and Neck Cancer
American College of Radiology Imaging Network 292
Testing effectiveness (Phase 2)Active Not RecruitingNCT03370276
What this trial is testing

Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the OropharynxSquamous Cell Carcinoma of the LarynxSquamous Cell Carcinoma of the Oral Cavity+5 more
H. Lee Moffitt Cancer Center and Research Institute 95
Early research (Phase 1)Ended earlyNCT01283178
What this trial is testing

Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC

Who this might be right for
Salivary Gland Squamous Cell CarcinomaStage II Salivary Gland CancerStage II Squamous Cell Carcinoma of the Hypopharynx+13 more
Virginia Commonwealth University 3
Large-scale testing (Phase 3)Active Not RecruitingNCT03952585
What this trial is testing

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

Who this might be right for
Basaloid Squamous Cell CarcinomaClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+5 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00002476
What this trial is testing

Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Cancer Research UK
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Not applicableEnded earlyNCT01096381
What this trial is testing

Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

Who this might be right for
Breast CancerCardiovascular ComplicationsColorectal Cancer+6 more
Vanderbilt-Ingram Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT03715946
What this trial is testing

Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer

Who this might be right for
Carcinoma, Squamous Cell of Head and NeckOropharynx Squamous Cell Carcinoma
Robert L. Ferris, MD, PhD 40
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Testing effectiveness (Phase 2)Ended earlyNCT00573989
What this trial is testing

Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Wake Forest University Health Sciences 27
Early research (Phase 1)Study completedNCT03144778
What this trial is testing

Durvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell Cancer

Who this might be right for
Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7
M.D. Anderson Cancer Center 39
Testing effectiveness (Phase 2)WithdrawnNCT02298595
What this trial is testing

Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Carcinoma, SquamousSquamous Cell CarcinomaOropharyngeal Neoplasms+1 more
Julie E. Bauman, MD, MPH
Testing effectiveness (Phase 2)Looking for participantsNCT02734537
What this trial is testing

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Who this might be right for
Head and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell Carcinoma+13 more
ECOG-ACRIN Cancer Research Group 189
Testing effectiveness (Phase 2)Study completedNCT01084083
What this trial is testing

Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer

Who this might be right for
Head and Neck CancerPrecancerous Condition
Eastern Cooperative Oncology Group 90
Early research (Phase 1)Study completedNCT00918762
What this trial is testing

Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx

Who this might be right for
Head and Neck CancerPerioperative/Postoperative ComplicationsPrecancerous Condition
Barbara Ann Karmanos Cancer Institute 6
Testing effectiveness (Phase 2)Ended earlyNCT02917629
What this trial is testing

ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment

Who this might be right for
Oral Cavity NeoplasmOropharyngeal NeoplasmStage 0 Oral Cavity Squamous Cell Carcinoma American Joint Committee on Cancer (AJCC) v6 and v7+11 more
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Study completedNCT01088802
What this trial is testing

Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx

Who this might be right for
Squamous Cell Carcinoma of Oropharynx
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Testing effectiveness (Phase 2)Study completedNCT00084318
What this trial is testing

Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 238
Not applicableNot Yet RecruitingNCT07241273
What this trial is testing

SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Squamous Cell CarcinomaOropharyngeal CancersOropharyngeal Carcinoma+3 more
UNICANCER 128
Load More Results
384